User menu

Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B.

Bibliographic reference Jonas, Maureen M ; Kelly, Deirdre ; Pollack, Henry ; Mizerski, Jacek ; Sorbel, Jeff ; et. al. Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B.. In: Hepatology (Baltimore, Md.), Vol. 47, no. 6, p. 1863-71 (2008)
Permanent URL http://hdl.handle.net/2078.1/21573
  1. Hoofnagle, N Engl J Med, 336, 247 (1997)
  2. Sokal, Gastroenterology, 114, 988 (1998)
  3. Jonas, N Engl J Med, 346, 1706 (2002)
  4. Marcellin, N Engl J Med, 348, 808 (2003)
  5. Hadziyannis, N Engl J Med, 348, 800 (2003)
  6. Peters, Gastroenterology, 126, 91 (2004)
  7. Zeng, HEPATOLOGY, 44, 108 (2006)
  8. Sokal, J Clin Pharmacol, 0 (2008)